Company Overview - Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics, particularly in wound care, with initial applications for burns and diabetic foot ulcers [1] - The company aims to revolutionize wound care management through its DeepView System, which provides objective assessments of wound healing potential [1] Product Details - The DeepView System utilizes multi-spectral imaging and algorithms to predict burn healing potential and has received Breakthrough Device Designation from the U.S. FDA in 2018 [5] - The system is designed to offer faster and more accurate treatment insights, improving patient outcomes and reducing healthcare costs [1] Compliance and Regulatory Progress - On December 20, 2024, the company received a letter from Nasdaq confirming compliance with all applicable listing standards, eliminating the need for a further hearing regarding compliance [5] - The company is also making progress towards its submission to the FDA, reflecting its commitment to innovation and excellence in serving stakeholders [3]
Spectral AI Announces Confirmation of Compliance of its Nasdaq Listing Requirements